| Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil. | |
| | |
MedLine Citation:
|
PMID: 16631944 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Keratoacanthoma centrifugum marginatum (KCM) is a rare variant of keratoacanthoma, characterized by progressive peripheral growth with concomitant healing of the central area of the tumor. We present a patient with KCM who was treated with topical 5% 5-fluorouracil. This is the third reported case of KCM treated with this agent. |
| | |
Authors:
|
Sayuri Yuge; Deise Aparecida Santos Godoy; Maria Carolina Coelho de Melo; Danilo Silveira Sousa; Cleverson Teixeira Soares |
Related Documents
:
|
9496534 - A case of a hereditary, late progressing sensory autonomic neuropathy. 1640234 - Progressive anarthria with secondary parkinsonism: a clinico-pathological case report. 21919934 - Sublingual immunotherapy in children with allergic rhinitis: quality of systematic revi... 22217614 - Valproic acid-induced eosinophilic pleural effusion: a case report and review of the li... 830874 - The treatment of pneumopericardium in the newborn infant. 16260884 - Prenatal diagnosis of a fetal chest wall cystic lymphangioma using ultrasonography and ... |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Journal of the American Academy of Dermatology Volume: 54 ISSN: 1097-6787 ISO Abbreviation: J. Am. Acad. Dermatol. Publication Date: 2006 May |
Date Detail:
|
Created Date: 2006-04-24 Completed Date: 2006-05-25 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7907132 Medline TA: J Am Acad Dermatol Country: United States |
Other Details:
|
Languages: eng Pagination: S218-9 Citation Subset: IM |
Affiliation:
|
Department of Dermatology, Instituto Lauro de Souza Lima, São Paulo, Brazil. sayuriyuge@zipmail.com.br |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged, 80 and over Dermatologic Agents / therapeutic use Female Fluorouracil / therapeutic use* Humans Keratoacanthoma / drug therapy*, pathology* Leg Methotrexate / therapeutic use Retreatment Skin / pathology Skin Diseases / drug therapy*, pathology* Treatment Failure Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Dermatologic Agents; 51-21-8/Fluorouracil; 59-05-2/Methotrexate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multifocal lymphangioendotheliomatosis with thrombocytopenia.
Next Document: Primary cutaneous paraganglioma of the scalp.